BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2004
View Archived Issues
Oral bisphosphonates prevent BMD loss in cystic fibrosis
Read More
Hormonal inhibitory effects of oral NOMA in male volunteers
Read More
Bristol-Myers Squibb presents CRF antagonists for treatment of anxiety
Read More
Oral recombinant human lactoferrin inhibits tumor growth
Read More
Monoclonal antibody effective against cancer progression in vivo
Read More
Dosing commences in phase IIa trial of BCX-1777
Read More
SnET2-PDT NDA submitted for AMD
Read More
Endo meets with FDA regarding oxymorphone approvable letter requirements
Read More
Japanese approval for Cypher sirolimus-eluting coronary stent
Read More
EMEA accepts Xyrem MAA for review
Read More
Enrollment completed in phase II trial of Liprostin for PVD
Read More
FDA accepts OrCel PMA
Read More
Completion of pilot study of Resurgex in immunocompromised patients
Read More
Feasibility study evaluates Tissue Repair Cells for nonunion large bone fractures
Read More
Gastrotech collaborates on IBS drug development
Read More
Interim results for BF-Derm1 shows reduction of urticaria symptoms
Read More
GlaxoSmithKline advances new Lp-PLA2 inhibitor into the clinic
Read More
Zyprexa Intramuscular approved for acute agitation
Read More
Antibacterial derivatives of lincomycin claimed in Vicuron patent
Read More
Potassium channel blockers emerge from ICAgen research
Read More
PDE4 inhibitors from Glenmark
Read More
Fujisawa discloses dual adenosine A1 and A2A receptor antagonists
Read More
Abbott patents azabicyclic compounds for treatment of pain
Read More
Monoamine reuptake inhibitors in early development at Pfizer
Read More
A VEGF-gelonin fusion protein inhibits metastasis to lung in a breast cancer model
Read More
PharmAthene files IND for clinical testing of ToxBlox
Read More
Preclinical data on the antitumor efficacy and hematological safety of C-1311
Read More
Synergistic effects of Targretin and cytotoxic agents in breast cancer and NSCLC
Read More
Systemic radioprotective effects found for CG-53135 in irradiated mice
Read More
Potent, selective VEGFR tyrosine kinase inhibitor presented by Pfizer at AACR meeting
Read More
Promising cytotoxic agent discovered at Taxolog
Read More
RWJ-540973, an ATP-competitive inhibitor of PDGFR kinase and autophosphorylation
Read More
Estrogen receptor beta agonist against rheumatoid arthritis
Read More
Further data on AP-23573 presented at AACR
Read More